Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07512297Phase 4Not yet recruiting
Phase 4, randomised trial of ibuprofen, acetaminophen and tenoxicam in procedural pain (4 arms), sponsored by Gaziantep University. Primary endpoint: Pain Intensity During Extracorporeal Shock Wave Lithotripsy (ESWL) Measured by Visual Analog Scale at 20 months. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07512297.